Article Details
Retrieved on: 2025-05-08 20:45:20
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses promising phase 3 trial results for Moderna's mRNA-1083 vaccine, combining flu and COVID-19 vaccines, showing higher immune responses compared to separate vaccinations. Tags and key concepts align with RNA vaccine research for COVID-19.
Article found on: www.cidrap.umn.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here